Ticared Tablet
Marketer
Medglobe Lifesciences Private Limited
Salt Composition
Ticagrelor (90mg)
Overview Ticared Tablet
CardioGuard tablets are classified as antiplatelet agents, also known as blood thinners. Their function is to inhibit the development of dangerous blood clots within blood vessels, thus lowering the risk of stroke or heart attack in individuals with cardiac conditions. CardioGuard is also indicated for patients recovering from a recent heart attack, experiencing severe angina (unstable chest pain), or who have received coronary stents. It helps prevent future cardiac events, including recurrent heart attacks, stroke, and clot formation within stents. Concurrent use with aspirin, another antiplatelet medication, is typically prescribed by your physician. CardioGuard can be administered with or without food, consistently at the same time daily. Continued use is crucial, even during periods of well-being, as discontinuation elevates the risk of recurrent cardiovascular events. The most frequent adverse effect is increased bleeding; injuries may bleed more profusely and for a longer duration. While usually mild and self-resolving, prolonged or excessive bleeding should be reported to your doctor. Some patients may experience mild shortness of breath, which typically subsides with continued therapy; however, worsening or persistent dyspnea requires medical attention. CardioGuard is contraindicated in individuals with active internal bleeding (e.g., stomach ulcer, intracranial hemorrhage) and those with hepatic impairment. Disclose any relevant medical history, particularly liver conditions, to your physician prior to commencing treatment.
Uses of Ticared Tablet
Reducing the risk of cardiovascular events
Major Benefits of Ticared Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Ticared Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While Ticared Tablet can be taken with or without food, consistent timing is recommended for optimal results.
Common Side effects of Ticared Tablet:
- Bleeding
- Breathlessness
How to use Ticared Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ticared Tablet can be consumed with or without food, although consistent timing is recommended for optimal results.
How Ticared Tablet works:
Ticagrelor tablets inhibit platelet aggregation, thus reducing the risk of dangerous thrombus formation and consequently lowering the likelihood of myocardial infarction or cerebrovascular accident.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Ticared Tablet concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Ticared Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Ticared Tablet use while breastfeeding is absent. Seek your physician's advice.
DrivingSAFE
Driving ability is typically unaffected by Ticared Tablet.
KidneySAFE IF PRESCRIBED
Ticared Tablet presents no safety concerns for patients with kidney impairment; dosage modification is unnecessary. Data regarding Ticared Tablet's use in individuals undergoing renal dialysis is currently limited.
LiverCAUTION
Patients with liver impairment should use Ticared Tablet cautiously, potentially requiring dose modification. Consult a physician before use. Ticared Tablet is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Ticared Tablet :
Should you forget a Ticared Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ticared Tablet
| Label | Value |
|---|---|
| Chemical Type | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | ADP receptor antagonists (P2Y12 inhibitors) |



